A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL)

Adrienne Alise Phillips; Paul Fields; Olivier Hermine; Juan Carlos Ramos; Brady Ernesto Beltran; Juliana Pereira; Carlos Brites; Michael R Kurman; Joyce George; Karen M Dwyer; Kevin Conlon; Graham P Taylor; Jason Parker Gonsky; Steven M Horwitz

doi:10.1200/JCO.2016.34.15_suppl.7501

$A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL)$

Journal article

Peer reviewed

A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL)

Adrienne Alise Phillips, Paul Fields, Olivier Hermine, Juan Carlos Ramos, Brady Ernesto Beltran, Juliana Pereira, Carlos Brites, Michael R Kurman, Joyce George, Karen M Dwyer, …

Journal of clinical oncology, Vol.34(15_suppl), pp.7501-7501

2016-05-20

DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.7501

Metrics

4 Record Views

9 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1464 HTLV-1
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL)
Creators: Adrienne Alise Phillips - New York Presbyterian/Weill Cornell Medical College, New York, NY
Paul Fields - Guys Hospital, London, United Kingdom
Olivier Hermine - Hospital Necker Service d'Hematologie, Paris, France
Juan Carlos Ramos - University of Miami/Sylvester Cancer Center, Miami, FL
Brady Ernesto Beltran - Edgardo Rebagliati Martins Hospital, Surco, Peru
Juliana Pereira - Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
Carlos Brites - Hospital Universitario Professor Edgar Santos, Salvador, Brazil
Michael R Kurman - Kyowa Kirin Pharmaceuticals, Upper Saddle River, NJ
Joyce George - Kyowa Kirin Pharmaceutical Development, Inc, Princeton, NJ
Karen M Dwyer - Kyowa Kirin Pharmaceuticals, Princeton, NJ
Kevin Conlon - National Cancer Institute, Bethesda, MD
Graham P Taylor - Imperial College, London, United Kingdom
Jason Parker Gonsky - State University of New York Downstate and Kings City Hospital Center, Brooklyn, NY
Steven M Horwitz - Memorial Sloan Kettering Cancer Center, New York, NY
Publication Details: Journal of clinical oncology, Vol.34(15_suppl), pp.7501-7501
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031599644902976